When Worlds Collide: Medicine,Business,the Affordable Care Act and the Future of Health Care in the U.S.

Churchill L. R. , “The Hegemony of Money: Commercialism and Professionalism in American Medicine,” Cambridge Quarterly of Healthcare Ethics, no. 16 (2007): 407–414.

Fins J. , “Commercialism in the Clinic: Finding Balance in Medical Professionalism,” Cambridge Quarterly of Healthcare Ethics, no. 16 (2007): 425–432.

Burns L. , “The Business of Healthcare Innovation in the Wharton School Curriculum,” in Burns L. , ed., The Business of Healthcare Innovation (Cambridge, UK: Cambridge University Press, 2002): At 1–36.

Timmermans S. Hyeyoung O. , “The Continued Social Transformation of the Medical Profession,” Journal of Health and Social Behavior (51, no. 5. (2010): S94–S106.

Brody H. , “Medicine's Ethical Responsibility for Health Care Reform – The Top Five List,” New England Journal of Medicine, no. 362 (2010): 283–285.

Starr P. : Remedy and Reaction (New Haven, CT: Yale University Press, 2013).

Gibson R. Singh J. P. , Medicare Meltdown: How Wall Street and Washington are Ruining Medicare and How to Fix It (Latham, MD: Rowman & Littlefield, 2013).

For example, Churchill , supra note 1;

Fins , supra note 1;

Medicare Meltdown, supra note 1;

Remedy and Reaction, supra note 1.

These arguments were originally articulated in Wicks A. , “Albert Schweitzer or Ivan Boesky? Why We Should Reject the Dichotomy between Medicine and Business,” Journal of Business Ethics, no. 14 (1995): 339–351, at 341–342.

Harrison J. Wicks A. C. , “Stakeholder Theory, Value, and Firm Performance,” Business Ethics Quarterly 23, no. 1 (2013): 97–123.

Id.

Smith A. , The Wealth of Nations (New York: Simon and Brown, 2014).

See Harrison Wicks , supra note 4, at 97.

Id.

Andereck W. , “From Patient to Consumer in the Medical Marketplace,” Cambridge Quarterly of Healthcare Ethics, no. 16 (2007): 109–113.

Churchill L. R. , “The Hegemony of Money: Commercialism and Professionalism in American Medicine,” Cambridge Quarterly of Healthcare Ethics, no. 16 (2007): 407–14.

See Andereck , supra note 9, at 109.

See Churchill , supra note 10, at 411.

See Fins , supra note 1, at 429.

Gilmartin M. Freeman R. , “Business Ethics and Health Care: A Stakeholder Perspective,” Health Care Management Review 27, no. 2 (2002): 52–65.

Id., at 52.

Id., at 52.

Freeman R. Harrison J. Wicks A. Parmar B. de Colle S. , Stakeholder Theory: The State of the Art (Cambridge: Cambridge University Press, 2010);

see Gilmartin Freeman , supra note 14.

Haidt J. , The Righteous Mind: Why Good People Are Divided by Politics and Religion (New York: Vintage, 2013);

id. (Stakeholder Theory).

Wicks A. , “The Business Ethics Movement: Where are We Headed and What Can We Learn from Our Colleagues in Bioethics?” Business Ethics Quarterly 5, no. 3 (1995): 603–20;

Wicks , supra note 3.

Freeman R. , Strategic Management: A Stakeholder Approach (Boston: Pitman, 1984).

Freeman R. , “The Politics of Stakeholder Theory: Some Future Directions,” Business Ethics Quarterly, no. 4 (1994): 409–421.

Id.

Solomon R. , Ethics and Excellence (Oxford: Oxford University Press, 1993).

Friedman M. , “The Social Responsibility of Business Is to Increase Its Profits,” New York Times Magazine (September 13, 1970): 32–33, 122–124.

See Freeman , supra note 21.

Nelson J. , Economics for Humans (Chicago: University of Chicago Press, 2006).

Frank R. , Passions within Reason: The Strategic Role of the Emotions (New York: W.W. Norton & Co., 1986).

Whole Foods Market, available at <http://www.wholefoodsmarket.com/mission-values/core-values/declaration-interde-pendence>(last visited June 2, 2014).

Mackey J. Sisodia R. , Conscious Capitalism: Liberating the Heroic Spirit of Business (Cambridge, MA: Harvard Business Review Press, 2013).

Mackey J. , “Conscious Capitalism: Creating a New Paradigm for Business,” FlowIdealism.org (2007), available at <http://www.flowidealism.org/2007/Downloads/Conscious-Capitalism_JM.pdf>(last visited June 2, 2014).

Collins J. Porras J. , Built to Last: Successful Habits of Visionary Companies (New York: Harper Business, 1994).

Hansen K. , “Merck and Co., Inc. (A)” (Cambridge, MA: Harvard Business Publishing, 1991), available at <http://hbr.org/product/merck-co-inc-addressing-third-world-needs-a/an/991021-PDF-ENG>(last visited June 2, 2014).

See Built to Last, supra note 30, at 16.

For a thorough discussion of systems thinking in business ethics, see P. Werhane, “Moral Imagination and Systems Thinking,” Journal of Business Ethics 38, nos. 1–2 (2002): 33–42.

See Rawls J. , A Theory of Justice (Cambridge: Belknap/Harvard University Press, 1971).

See Kinney E. , “For Profit Enterprise in Health Care: Can It Contribute to Health Reform?” American Journal of Law & Medicine 36, nos. 2&3 (405–35): 405–435, at 418.

Id., at 418, 424.

See Moses H. Matheson D. Dorsey E. George B. Sadoff D. Yoshimura S. , “The Anatomy of Health Care in the United States,” JAMA 310, no. 18 (2013): 1947–1963, at 1961.

Porter M. Tiesberg E. , “How Physicians Can Change the Future of Health Care,” JAMA 297, no. 10 (2007): 1103–11.

Id.

See Relman A. , “What Market Values Are Doing to Medicine,” Atlantic Monthly (March 1992), at 106.

Ruger T. , “Can a Patient-Centered Ethos Be Other-Regarding? Ought It Be?” Wake Forest Law Review 45 (2010): 1513–1523. Ruger notes this tension and the difficulty of providing these benefits within the current system and hoping that they will be used responsibly.

Id., at 1521–22.

Id., at 1522.

Goodstein J. Wicks A. , “Corporate and Stakeholder Responsibility: Making Business Ethics and Two-Way Conversation,” Business Ethics Quarterly 17, no. 3 (2007): 375–398;

Elms H. Phillips R. , “Private Security Companies and Institutional Legitimacy: Corporate and Stakeholder Responsibility,” Business Ethics Quarterly 19, no. 3 (2009): 403–432.

See Kinney , supra note 35, at 418.

See Righteous Mind, supra note 18.

Milgram S. , Obedience to Authority (New York: Harper Collins, 1974).

Haney C. Banks W. Zimbardo P. , “Interpersonal Dynamics in a Simulated Prison,” International Journal of Criminology and Penology, no. 1 (1973): 69–97.

Tax S. Brown S. , “Recovering and Learning from Service Failure,” Sloan Management Review 40 (1998): 75–88.

Id.

Woolhandler S. Ariely D. Himmelstein D. , “Why Pay for Performance May Be Incompatible with Quality Improvement,” BMJ 345 (2012): e5015.

Glasziou P. Buchan H. Del Mar C. Doust J. Harris M. Knight R. , “When Financial Incentives Do More Good Than Harm: A Checklist,” BMJ 345 (2012): e5047.

Id. ( Woolhandler ).

Song Y. Skinner J. Bynum J. Sutherland J. Wennberg J. Fisher E. , “Regional Variations in Diagnostic Practices,” New England Journal of Medicine 363 (2010): 45–53.

Welch H. Sharp S. Gottlieb D. Skinner J. Wennberg J. , “Geographic Variation in Diagnosis Frequency and Risk of Death among Medicare Beneficiaries,” JAMA 305 (2011): 1113–1118.

Green A. Carney D. Pallin D. Ngo L. Raymond K. Iezzoni L. Banaji M. , “Implicit Bias among Physicians and Its Prediction of Thrombolysis Decisions for Black and White Patients,” Journal of General Internal Medicine 22, no. 9 (2007): 1231–1238.

See Woolhandler , supra note 51.

Welch , supra note 53.

Fernandez-Dols J. Aguilar P. Campo S. Vallacher R. Janowsky A. Rabbia H. Brussino S. Lerner M. , “Hypocrites or Maligned Cooperative Participants? Experimenter Induced Normative Conflict in Zero-Sum Situations,” Journal of Experimental Social Psychology 46, no. 3 (2010): 525–530.

See, for example, Hsieh P. , “How Obama Care Creates Ethical Conflicts for Physicians and How Patients Can Protect Themselves,” Forbes (January 28, 2014), available at <http://www.forbes.com/sites/paulhsieh/2014/01/28/how-obamacare-creates-ethical-conflicts-for-physicians/>(last visited June 2, 2014).

Korenstein D. Falk R. Howell E. Bishop T. Keyhani S. , “Overuse of Health Care Services in the United States: An Understudied Problem,” Archives of Internal Medicine 172, no. 2 (2012): 171–178.

Angus D. Barnato A. Linde-Zwirble W. Weissfeld L. Watson R. Rickert T. Rubenfeld G. , “Use of Intensive Care at the End of Life in the United States: An Epidemiologic Study,” Critical Care Medicine 32, no. 3 (2004): 638–643.